Evidence map›Paper›PMID 27917951›Full record

ArticleScientific reports2016

Catalytic Conversion of Lipophilic Substrates by Phase constrained Enzymes in the Aqueous or in the Membrane Phase.

Marcus Cebula, Ilke Simsek Turan, Birgitta Sjödin, Madhuranayaki Thulasingam, Joseph Brock, Volodymyr Chmyrov, Jerker Widengren, Hiroshi Abe, Bengt Mannervik, Jesper Z Haeggström and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Marcus CebulaInstitute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, 17177, Stockholm, Sweden.
Ilke Simsek TuranUNAM-Institute of Material Science and Nanotechnology, Bilkent University, Bilkent, Ankara, 06800, Turkey.
Birgitta SjödinDepartment of Neurochemistry, Stockholm University, Svante Arrhenius väg 16C, 10691, Stockholm, Sweden.
Madhuranayaki ThulasingamDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles väg 2, 17177, Stockholm, Sweden.
Joseph BrockDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles väg 2, 17177, Stockholm, Sweden.
Volodymyr ChmyrovExperimental Biomolecular Physics, Royal Institute of Technology-KTH, Albanova, Roslagsvägen 30 B, 11419, Stockholm, Sweden.
Jerker WidengrenExperimental Biomolecular Physics, Royal Institute of Technology-KTH, Albanova, Roslagsvägen 30 B, 11419, Stockholm, Sweden.
Hiroshi AbeDepartment of Chemistry, Graduate School of Science, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8602, Japan.
Bengt MannervikDepartment of Neurochemistry, Stockholm University, Svante Arrhenius väg 16C, 10691, Stockholm, Sweden.
Jesper Z HaeggströmDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles väg 2, 17177, Stockholm, Sweden.
Agnes Rinaldo-MatthisDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles väg 2, 17177, Stockholm, Sweden.
Engin U AkkayaDepartment of Chemistry &UNAM-Institute of Material Science and Nanotechnology, Bilkent University, Bilkent, Ankara, 06800, Turkey.
Ralf MorgensternInstitute of Environmental Medicine, Karolinska Institutet, Nobels väg 13, 17177, Stockholm, Sweden.
Karolinska Institutet · SEBilkent University · TRKTH Royal Institute of Technology · SEStockholm University · SENagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both soluble and membrane-bound enzymes can catalyze the conversion of lipophilic substrates. The precise substrate access path, with regard to phase, has however, until now relied on conjecture from enzyme structural data only (certainly giving credible and valuable hypotheses). Alternative methods have been missing. To obtain the first experimental evidence directly determining the access paths (of lipophilic substrates) to phase constrained enzymes we here describe the application of a BODIPY-derived substrate (PS1). Using this tool, which is not accessible to cytosolic enzymes in the presence of detergent and, by contrast, not accessible to membrane embedded enzymes in the absence of detergent, we demonstrate that cytosolic and microsomal glutathione transferases (GSTs), both catalyzing the activation of PS1, do so only within their respective phases. This approach can serve as a guideline to experimentally validate substrate access paths, a fundamental property of phase restricted enzymes. Examples of other enzyme classes with members in both phases are xenobiotic-metabolizing sulphotransferases/UDP-glucuronosyl transferases or epoxide hydrolases. Since specific GSTs have been suggested to contribute to tumor drug resistance, PS1 can also be utilized as a tool to discriminate between phase constrained members of these enzymes by analyzing samples in the absence and presence of Triton X-100.

Indexed as

AnimalsBiocatalysisBoron CompoundsCytosolEnzymes, ImmobilizedEpoxide HydrolasesEukaryotic CellsFluorescent DyesGlucuronosyltransferaseGlutathione TransferaseHumansHydrophobic and Hydrophilic InteractionsInactivation, MetabolicKineticsMicrosomesModels, Molecular4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneBoron CompoundsEnzymes, ImmobilizedEpoxide HydrolasesFluorescent DyesGlucuronosyltransferaseGlutathione TransferaseOctoxynolSulfotransferasesXenobiotics

Identifiers

PMID27917951
PMCPMC5137027
OpenAlexW2560443337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.